No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AIXI Xiao-I
- 1.265
- +0.055+4.55%
Trading May 8 14:00 ET
91.14MMarket Cap-3446P/E (TTM)
1.320High1.150Low137.99KVolume1.200Open1.210Pre Close172.01KTurnover0.39%Turnover RatioLossP/E (Static)72.05MShares10.39052wk High-18.60P/B44.40MFloat Cap1.13052wk Low--Dividend TTM35.10MShs Float10.390Historical High--Div YieldTTM14.05%Amplitude1.130Historical Low1.246Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Xiao-I Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Xiao-I Corporation (NASDAQ:AIXI) Might Not Be As Mispriced As It Looks After Plunging 31%
Xiao-I Corporation (NASDAQ:AIXI) shareholders that were waiting for something to happen have been dealt a blow with a 31% share price drop in the last month. For any long-term shareholders, the las
Earnings Call Summary | Xiao-I(AIXI.US) Q4 2023 Earnings Conference
The following is a summary of the Xiao-I Corporation (AIXI) Q4 2023 Earnings Call Transcript:Financial Performance:Xiao-I reported Q4 revenue of $59.2 million, a rise of 22.8% year-on-year.Significant
Express News | Xiao-I Announced The Forthcoming Launch Of Its Innovative Product, Dif (Daily Invest Focus), In May 2024
Express News | XIAO-I FY EPS $(1.12) Down From $(0.27) YoY, Sales $59.17M Up From $48.18M YoY
Express News | Xiao-I Corporation Reports Unaudited Full Year 2023 Financial Results
Comments
$Global Engine Group(GLE.US$ supposed to be listed today and the underwritter Prime Number Capital has had some pretty good runners this year. $Northann(NCL.US$ $Global Mofy Metaverse(GMM.US$ $Ispire Technology(ISPR.US$ $Jin Medical International(ZJYL.US$ $Ohmyhome(OMH.US$ Also did $Nature Wood Group(NWGL.US$ $Xiao-I(AIXI.US$.... $Warrantee(WRNT.US$ is doing god awful but can't win every listing.
1
1
$Shuttle Pharmaceuticals(SHPH.US$
On August 29, 2023, Shuttle Pharmaceuticals Holdings, Inc. has published a groundbreaking manuscript revealing the potential of their innovative selective HDAC6 inhibitor, SP-2-225, to enhance antitumor immune responses and inhibit tumor growth.
This combination therapy with radiation therapy holds immense promise in the fight against cancer, and could revolutionize the field of oncology.
![]()
![]()
![]()
...
On August 29, 2023, Shuttle Pharmaceuticals Holdings, Inc. has published a groundbreaking manuscript revealing the potential of their innovative selective HDAC6 inhibitor, SP-2-225, to enhance antitumor immune responses and inhibit tumor growth.
This combination therapy with radiation therapy holds immense promise in the fight against cancer, and could revolutionize the field of oncology.
2
$Xiao-I(AIXI.US$ $Apellis Pharmaceuticals(APLS.US$ $The Arena Group(AREN.US$ $Bentley Systems(BSY.US$ $Ebix Inc(EBIX.US$ $Evelo Biosciences(EVLO.US$ $Getty Images(GETY.US$ $Home Depot(HD.US$ $Hanryu Holdings(HRYU.US$ $Navitas Semiconductor(NVTS.US$ $Rigetti Computing(RGTI.US$ $SoundHound AI(SOUN.US$ $Target(TGT.US$ $Valero Energy(VLO.US$ $Walmart(WMT.US$ $Wynn Resorts(WYNN.US$
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Mini0nOP : Moved to 28th looks like